Literature DB >> 6405444

Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory evoked potentials.

M S Buchsbaum, G C Davis, D Naber, D Pickar.   

Abstract

The effect of 8 mg IV naloxone on pain appreciation was studied with electric shocks administered to the left forearm of 20 normal volunteers. Pain sensitivity was assessed with a psychophysical task and with evoked potentials (EP) to the pain stimuli which were found sensitive to opiate agonists and antagonists in previous experiments. Naloxone-induced hyperalgesia before and after 20 min of intermittent shock was assessed in a 3-day placebo crossover experiment designed to provide control comparisons of time effects. EP amplitude enhancement with naloxone was significantly greater following 20 min of shocks than preceding them, while pain judgments were not significantly affected. Thus, naloxone increases pain sensitivity, especially after prolonged pain stimulation. This finding is consistent with endorphin mediation of stress-induced analgesia and raises the question of whether this type of response decrement over time is related to the phenomena of habituation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405444     DOI: 10.1007/BF00427792

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  The measurement of pain; prototype for the quantitative study of subjective responses.

Authors:  H K BEECHER
Journal:  Pharmacol Rev       Date:  1957-03       Impact factor: 25.468

2.  Analgesia induced in vivo by central administration of enkephalin in rat.

Authors:  J D Belluzzi; N Grant; V Garsky; D Sarantakis; C D Wise; L Stein
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

3.  Auditory analgesia: somatosensory evoked response and subjective pain rating.

Authors:  R Lavine; M S Buchsbaum; M Poncy
Journal:  Psychophysiology       Date:  1976-03       Impact factor: 4.016

4.  Evidence for analgesic activity of enkephalin in the mouse.

Authors:  H H Buscher; R C Hill; D Römer; F Cardinaux; A Closse; D Hauser; J Pless
Journal:  Nature       Date:  1976-06-03       Impact factor: 49.962

5.  Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials.

Authors:  G C Davis; M S Buchsbaum; W E Bunney
Journal:  Life Sci       Date:  1978-10-09       Impact factor: 5.037

6.  Placebo analgesia, endorphins, and naloxone.

Authors:  A Goldstein; P Grevert
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

7.  Altered pain perception and cerebrospinal endorphins in psychiatric illness.

Authors:  G C Davis; M S Buchsbaum; D Naber; D Pickar; R Post; D van Kammen; W E Bunney
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

8.  The influence of naloxone on analgesia produced by peripheral conditioning stimulation.

Authors:  B H Sjölund; M B Eriksson
Journal:  Brain Res       Date:  1979-09-14       Impact factor: 3.252

9.  Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects.

Authors:  P Grevert; A Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

10.  Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes.

Authors:  J C Willer; H Dehen; J Cambier
Journal:  Science       Date:  1981-05-08       Impact factor: 47.728

View more
  8 in total

1.  Withdrawal following sufentanil/propofol and sufentanil/midazolam. Sedation in surgical ICU patients: correlation with central nervous parameters and endogenous opioids.

Authors:  Maria Korak-Leiter; Rudolf Likar; Michael Oher; Ernst Trampitsch; Gerda Ziervogel; Joseph V Levy; Enno C Freye
Journal:  Intensive Care Med       Date:  2005-02-16       Impact factor: 17.440

2.  Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response.

Authors:  J J Lipman; B E Miller; K S Mays; M N Miller; W C North; W L Byrne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  The effects of naloxone on opiate and placebo analgesia in healthy volunteers.

Authors:  J Posner; C A Burke
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Nociceptive flexion reflex and pain rating responses during endogenous opiate blockade with naltrexone in healthy young adults.

Authors:  Christopher R France; Mustafa al'Absi; Christopher Ring; Janis L France; Angie Harju; Lorentz E Wittmers
Journal:  Biol Psychol       Date:  2006-12-27       Impact factor: 3.251

5.  The effect of opioid receptor blockade on the neural processing of thermal stimuli.

Authors:  Eszter D Schoell; Ulrike Bingel; Falk Eippert; Juliana Yacubian; Kerrin Christiansen; Hilke Andresen; Arne May; Christian Buechel
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

6.  Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters.

Authors:  G Kobal; C Hummel; B Nuernberg; K Brune
Journal:  Agents Actions       Date:  1990-03

7.  Promethazine both facilitates and inhibits nociception in rats: effect of the testing procedure.

Authors:  G H Paalzow; L K Paalzow
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 8.  Endogenous opioid antagonism in physiological experimental pain models: a systematic review.

Authors:  Mads U Werner; Manuel P Pereira; Lars Peter H Andersen; Jørgen B Dahl
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.